SCHEMBL3479558

SCHEMBL3479558

CN1CCN(c2ccccc2)c2ccc(-n3cncn3)cc2C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 1/20 0.39
BRD4 O60885 4/20 0.37
ROCK2 O75116 1/20 0.37
CYP2A6 P11509 1/20 0.37
PRMT5 O14744 1/20 0.36
WDR77 Q9BQA1 1/20 0.36
CREBBP Q92793 2/20 0.35
WNT1 P04628 1/20 0.35
DYRK1A Q13627 1/20 0.35
HSD11B1 P28845 1/20 0.35
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MAPK10 P53779 1/20 0.34
HTR1D P28221 1/20 0.34
HTR1B P28222 1/20 0.34
FAAH O00519 1/20 0.33
MGLL Q99685 1/20 0.33
HCRTR1 O43613 1/20 0.33
HCRTR2 O43614 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3479654 0.89 BRD4 (0.48) SCN9ABRD4ROCK2CREBBPWNT1
SCHEMBL3217500 0.89 HSD11B1 (0.39) SCN9ABRD4ROCK2CREBBPWNT1
SCHEMBL3479595 0.89 HTR3A (0.44) SCN9ABRD4ROCK2PRMT5WDR77
SCHEMBL3229454 0.86 HSD11B1 (0.36) SCN9ABRD4ROCK2PRMT5WDR77
SCHEMBL3479681 0.85 BRD4 (0.36) SCN9ABRD4ROCK2CREBBPWNT1
SCHEMBL3479666 0.82 DRD2 (0.40) SCN9AKDM4EALDH1A1HTR1DHTR1B
SCHEMBL3479777 0.79 ADRA2C (0.51) SCN9AKDM4EALDH1A1HTR1BDRD3
SCHEMBL3238745 0.77 ALDH1A1 (0.48) SCN9AHSD11B1ALDH1A1LMNA
SCHEMBL3226224 0.76 SCN9A (0.45) SCN9ABRD4HTR1BHTR6CYP1A2
SCHEMBL3235658 0.75 SLC6A2 (0.43) SCN9ABRD4KDM4EALDH1A1BRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096546-B2 Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin ALBANY MOLECULAR RESEARCH, INC. (US) 2015-08-04 US disclosed
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ALBANY MOLECULAR RESEARCH, INC. (US) 2010-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ADRA1B, ADRB1, ADRA1D SCN9A 795/4885BRD4 172/4885ROCK2 2192/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.